MSCI: As Credit Risk Rises, Beware of Selection Bias in CLOs

Investors in the booming U.S. Collateralized Loan Obligation (CLO) market likely need to be aware of the risks: record tight spreads,1 deteriorating credit quality, and, as our expanded CLO data analytics reveal, selection bias risk.

The U.S. CLO market achieved a new record in 2017. New issuance exceeded USD 240 billion and reset and refinancing deals were about twice 2016’s volume. However, the credit quality of CLO collateral has been deteriorating. The exhibit below shows the trend in

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risktech Forum? Register for access

RiskTech100® Winner’s Profile: Moody's

Moody’s celebrates its first year at the top of the RiskTech100 rankings. This marks a stellar year for the Overall Winner, with the firm taking home 15 additional individual awards, its largest haul in the 17-year history of the RiskTech100.

RiskTech100® Rising Star Profile: Vneuron

Vneuron Risk & Compliance is a ‘Rising Star’ in this year’s Chartis’ RiskTech100 awards. The fast-growing, French-headquartered firm is on a mission to fight money laundering and combat terrorism financing. It has been recognized by Chartis for the…

Chartis Big Bets 2022

Chartis’ annual Big Bets report outlines our major predictions for the year ahead, highlighting some of the key market trends, risk areas and core technologies that form the basis of our 2022 report agenda.

You need to sign in to use this feature. If you don’t have a RiskTech Forum account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can contact us to request an individual account here.